Monopar Therapeutics Reports Third Quarter 2023 Financial Results and Recent Developments
Go back to Monopar Therapeutics Reports Third Quarter 2023 Financial Results and Recent Developments| (NASDAQ: MNPR) | Delayed: 116.28 -1.29 (1.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $117.57 | 52 Week High | $ | |||
| Open | $119.04 | 52 Week Low | $ | |||
| Day High | $121.00 | P/E | N/A | |||
| Day Low | $114.28 | EPS | $ | |||
| Volume | 203,353 | |||||

